Regulus Therapeutics Inc.
RGLS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $39 | $24 | $24 | $60 |
| Short-Term Investments | $37 | $0 | $15 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $3 | $3 | $3 |
| Other Curr. Assets | $7 | $1 | $2 | $2 |
| Total Curr. Assets | $82 | $28 | $44 | $65 |
| Property Plant & Equip (Net) | $2 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $3 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $84 | $31 | $47 | $68 |
| Liabilities | – | – | – | – |
| Payables | $1 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $1 | $5 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | -$1 |
| Other Curr. Liab. | $7 | $7 | $7 | $4 |
| Total Curr. Liab. | $7 | $9 | $12 | $5 |
| LT Debt | $0 | $1 | $2 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $1 |
| Total NC Liab. | $0 | $1 | $2 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $2 | $3 |
| Total Liabilities | $8 | $10 | $13 | $13 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$560 | -$513 | -$483 | -$455 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $636 | $534 | $516 | $510 |
| Total Equity | $76 | $21 | $33 | $55 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $84 | $31 | $47 | $68 |
| Net Debt | -$38 | -$21 | -$18 | -$52 |